Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fox Co. stock logo
FOX
FOX
$30.80
+0.7%
$28.17
$25.82
$33.24
$14.63B0.821.27 million shs1.21 million shs
General Motors stock logo
GM
General Motors
$45.36
+0.7%
$43.14
$26.30
$46.17
$51.75B1.4916.82 million shs9.35 million shs
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$34.10
-3.9%
$39.46
$25.43
$44.16
$4.59B1.481.82 million shs3.93 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$771.55
-0.4%
$761.56
$419.80
$800.78
$733.28B0.373.07 million shs2.17 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$130.23
+0.5%
$126.48
$99.14
$133.10
$329.85B0.398.20 million shs9.10 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.20
-0.2%
$26.94
$25.20
$40.37
$159.66B0.6343.59 million shs47.81 million shs
TEGNA Inc. stock logo
TGNA
TEGNA
$15.03
+2.4%
$14.22
$13.18
$17.37
$2.65B0.52.14 million shs2.47 million shs
THOR Industries, Inc. stock logo
THO
THOR Industries
$104.68
+1.7%
$106.83
$75.93
$129.31
$5.58B1.8467,620 shs695,719 shs
Viatris Inc. stock logo
VTRS
Viatris
$11.22
-5.0%
$11.76
$8.74
$13.62
$13.36B1.139.29 million shs15.23 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fox Co. stock logo
FOX
FOX
+0.69%+5.30%+6.94%+12.20%+7.54%
General Motors stock logo
GM
General Motors
+0.68%+1.54%+1.41%+17.63%+37.12%
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
-3.89%-2.63%-20.48%-7.46%-0.23%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-0.45%+2.07%+1.89%+4.24%+76.99%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.58%+1.54%+2.78%+3.81%+10.46%
Pfizer Inc. stock logo
PFE
Pfizer
-0.28%+1.79%+5.30%+2.32%-26.38%
TEGNA Inc. stock logo
TGNA
TEGNA
+2.38%+6.22%+5.10%+4.81%-4.93%
THOR Industries, Inc. stock logo
THO
THOR Industries
+1.75%+6.06%-7.31%-11.60%+32.06%
Viatris Inc. stock logo
VTRS
Viatris
-5.00%-3.28%-5.08%-3.94%+17.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fox Co. stock logo
FOX
FOX
1.5042 of 5 stars
0.03.01.72.92.20.81.3
General Motors stock logo
GM
General Motors
4.8373 of 5 stars
3.44.02.50.01.92.53.8
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
4.7559 of 5 stars
4.44.02.50.01.31.72.5
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.732 of 5 stars
2.43.02.54.02.61.73.1
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.7509 of 5 stars
2.33.03.34.12.62.52.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9893 of 5 stars
4.23.04.24.83.61.71.9
TEGNA Inc. stock logo
TGNA
TEGNA
2.675 of 5 stars
2.23.02.50.02.52.51.3
THOR Industries, Inc. stock logo
THO
THOR Industries
4.072 of 5 stars
1.32.04.21.53.21.73.1
Viatris Inc. stock logo
VTRS
Viatris
0.5136 of 5 stars
0.72.02.50.01.92.50.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fox Co. stock logo
FOX
FOX
N/AN/AN/AN/A
General Motors stock logo
GM
General Motors
2.76
Moderate Buy$54.6520.47% Upside
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
2.71
Moderate Buy$46.4336.15% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.84
Moderate Buy$757.95-1.76% Downside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.58
Moderate Buy$131.330.85% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.0027.68% Upside
TEGNA Inc. stock logo
TGNA
TEGNA
2.33
Hold$17.0013.11% Upside
THOR Industries, Inc. stock logo
THO
THOR Industries
2.60
Moderate Buy$104.00-0.65% Downside
Viatris Inc. stock logo
VTRS
Viatris
1.33
Sell$11.00-1.96% Downside

Current Analyst Ratings

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $29.00
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$33.00 ➝ $36.00
5/1/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$900.00 ➝ $1,001.00
5/1/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$850.00 ➝ $900.00
5/1/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$850.00 ➝ $892.00
4/30/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$815.00 ➝ $885.00
4/26/2024
General Motors stock logo
GM
General Motors
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.00
4/26/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$50.00 ➝ $45.00
4/26/2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$142.00 ➝ $143.00
4/25/2024
General Motors stock logo
GM
General Motors
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$55.00
4/24/2024
General Motors stock logo
GM
General Motors
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$95.00 ➝ $96.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fox Co. stock logo
FOX
FOX
$14.56B1.00$4.79 per share6.43$20.95 per share1.47
General Motors stock logo
GM
General Motors
$171.84B0.30$19.72 per share2.30$59.07 per share0.77
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$5.78B0.79$6.73 per share5.07$23.35 per share1.46
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$35.93B20.41$8.01 per share96.37$11.44 per share67.44
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$61.40B5.37$3.11 per share41.91$14.85 per share8.77
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.73$3.02 per share9.34$15.81 per share1.78
TEGNA Inc. stock logo
TGNA
TEGNA
$2.91B0.91$2.60 per share5.77$13.73 per share1.09
THOR Industries, Inc. stock logo
THO
THOR Industries
$10.38B0.54$13.02 per share8.04$74.72 per share1.40
Viatris Inc. stock logo
VTRS
Viatris
$15.43B0.87$4.99 per share2.25$17.06 per share0.66

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fox Co. stock logo
FOX
FOX
$1.24B$1.6918.22N/A5.75%15.81%7.39%8/13/2024 (Estimated)
General Motors stock logo
GM
General Motors
$10.13B$8.185.554.740.536.13%14.40%3.81%7/23/2024 (Estimated)
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$706.59M$4.507.586.931.1211.03%19.48%5.21%7/25/2024 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.24B$6.79113.6340.911.4517.08%56.98%10.94%8/13/2024 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$365M$0.90144.7013.141.633.76%14.15%5.24%8/6/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.251.17-0.56%8.58%3.70%8/6/2024 (Estimated)
TEGNA Inc. stock logo
TGNA
TEGNA
$476.72M$2.266.657.52N/A16.38%12.41%5.07%8/1/2024 (Estimated)
THOR Industries, Inc. stock logo
THO
THOR Industries
$374.27M$5.0420.7713.92N/A2.62%7.28%3.92%6/4/2024 (Estimated)
Viatris Inc. stock logo
VTRS
Viatris
$54.70M$0.04280.504.08N/A0.35%17.03%7.28%N/A

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q1 24
Viatris Inc. stock logo
VTRS
Viatris
$0.67$0.67N/AN/A$3.69 billion$3.65 billion    
5/8/2024Q1 2024
TEGNA Inc. stock logo
TGNA
TEGNA
$0.43$0.45+$0.02-$0.16$718.86 million$714.30 million    
5/6/2024Q1 2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$2.53$2.58+$0.05$2.68$8.94 billion$8.77 billion      
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    
4/25/2024Q1 2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$1.48$1.72+$0.24$1.72$1.42 billion$1.48 billion    
4/25/2024Q1 2024
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$1.94$2.07+$0.13$2.27$15.21 billion$15.78 billion    
4/23/2024Q1 24
General Motors stock logo
GM
General Motors
$2.02$2.62+$0.60$2.68$41.09 billion$43.01 billion      
3/6/202401/31/2024
THOR Industries, Inc. stock logo
THO
THOR Industries
$0.67$0.13-$0.54$0.67$2.27 billion$2.21 billion    
2/29/2024Q4 2023
TEGNA Inc. stock logo
TGNA
TEGNA
$0.47$0.43-$0.04$0.46$750.78 million$725.80 million      
2/28/2024Q4 23
Viatris Inc. stock logo
VTRS
Viatris
$0.65-$0.64-$1.29$1.86$3.91 billion$3.83 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fox Co. stock logo
FOX
FOX
$0.521.69%+3.50%30.77%3 Years
General Motors stock logo
GM
General Motors
$0.481.06%-1.79%5.87%1 Years
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$0.692.02%+14.47%15.33%4 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.200.67%+15.15%76.58%10 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.082.37%+6.08%342.22%13 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.685.96%+2.57%N/A 15 Years
TEGNA Inc. stock logo
TGNA
TEGNA
$0.452.99%+14.24%19.91%1 Years
THOR Industries, Inc. stock logo
THO
THOR Industries
$1.921.83%+4.71%38.10%14 Years
Viatris Inc. stock logo
VTRS
Viatris
$0.484.28%N/A1,200.00%N/A

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2024
TEGNA Inc. stock logo
TGNA
TEGNA
quarterly$0.12503.4%6/7/20246/7/20247/1/2024
4/22/2024
General Motors stock logo
GM
General Motors
quarterly$0.121.11%6/7/20246/7/20246/20/2024
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
5/9/2024
Viatris Inc. stock logo
VTRS
Viatris
quarterly$0.124.06%5/24/20246/14/2024
5/6/2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.300.69%5/15/20245/16/20246/10/2024
3/26/2024
THOR Industries, Inc. stock logo
THO
THOR Industries
Quarterly$0.481.67%4/8/20244/9/20244/23/2024
2/21/2024
TEGNA Inc. stock logo
TGNA
TEGNA
Quarterly$0.11403.14%3/7/20243/8/20244/1/2024
2/16/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
quarterly$0.17251.82%3/1/20243/4/20243/20/2024
2/26/2024
Viatris Inc. stock logo
VTRS
Viatris
quarterly$0.123.63%3/8/20243/11/20243/18/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fox Co. stock logo
FOX
FOX
0.70
2.29
2.01
General Motors stock logo
GM
General Motors
1.22
1.16
0.97
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
1.50
1.54
1.32
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.90
1.35
1.03
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.89
1.25
1.00
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69
TEGNA Inc. stock logo
TGNA
TEGNA
1.14
2.48
2.48
THOR Industries, Inc. stock logo
THO
THOR Industries
0.35
1.75
0.65
Viatris Inc. stock logo
VTRS
Viatris
0.79
1.67
1.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Fox Co. stock logo
FOX
FOX
26.41%
General Motors stock logo
GM
General Motors
92.67%
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
85.10%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
TEGNA Inc. stock logo
TGNA
TEGNA
92.19%
THOR Industries, Inc. stock logo
THO
THOR Industries
96.71%
Viatris Inc. stock logo
VTRS
Viatris
79.88%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Fox Co. stock logo
FOX
FOX
10,400474.88 million383.65 millionOptionable
General Motors stock logo
GM
General Motors
163,0001.14 billion1.13 billionOptionable
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
6,400134.53 million133.36 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
43,000950.41 million949.17 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
72,0002.53 billion2.53 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable
TEGNA Inc. stock logo
TGNA
TEGNA
6,200176.11 million174.56 millionOptionable
THOR Industries, Inc. stock logo
THO
THOR Industries
24,90053.33 million50.82 millionOptionable
Viatris Inc. stock logo
VTRS
Viatris
38,0001.19 billion1.19 billionOptionable

THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Headlines

SourceHeadline
Stocks Rise on Fed Rate Cut HopesStocks Rise on Fed Rate Cut Hopes
theglobeandmail.com - May 9 at 10:47 PM
VTRS Stock Earnings: Viatris Meets EPS, Misses Revenue for Q1 2024VTRS Stock Earnings: Viatris Meets EPS, Misses Revenue for Q1 2024
investorplace.com - May 9 at 1:13 PM
Viatris (VTRS) Q1 Earnings & Sales Lag Estimates, Stock DownViatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
zacks.com - May 9 at 12:11 PM
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesViatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com - May 9 at 11:31 AM
Viatris (VTRS) Q1 Earnings and Revenues Miss EstimatesViatris (VTRS) Q1 Earnings and Revenues Miss Estimates
zacks.com - May 9 at 9:10 AM
Viatris Inc. 2024 Q1 - Results - Earnings Call PresentationViatris Inc. 2024 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 9 at 8:48 AM
Viagra maker Viatris misses revenue estimates on weak demand for older drugsViagra maker Viatris misses revenue estimates on weak demand for older drugs
reuters.com - May 9 at 8:32 AM
Viatris Inc. Q1 Profit Drops, Inline With EstimatesViatris Inc. Q1 Profit Drops, Inline With Estimates
markets.businessinsider.com - May 9 at 8:20 AM
Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance RangesViatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
prnewswire.com - May 9 at 6:59 AM
Viatris Q1 Earnings Preview: Focus remains on capital allocationViatris Q1 Earnings Preview: Focus remains on capital allocation
msn.com - May 8 at 5:19 PM
Why Earnings Season Could Be Great for Viatris (VTRS)Why Earnings Season Could Be Great for Viatris (VTRS)
zacks.com - May 8 at 12:21 PM
Viatris is about to announce its earnings — heres what Wall Street expectsViatris is about to announce its earnings — here's what Wall Street expects
markets.businessinsider.com - May 8 at 9:39 AM
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
zacks.com - May 6 at 11:41 AM
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
zacks.com - May 6 at 10:51 AM
Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesViatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
zacks.com - May 6 at 10:21 AM
Viatris to Participate in the BofA Securities 2024 Health Care ConferenceViatris to Participate in the BofA Securities 2024 Health Care Conference
prnewswire.com - May 2 at 5:00 PM
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
zacks.com - May 2 at 11:06 AM
Viatris partners with Unmind on mental health in the workplaceViatris partners with Unmind on mental health in the workplace
bizjournals.com - May 1 at 4:11 PM
Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthViatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
prnewswire.com - May 1 at 6:59 AM
Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.
seekingalpha.com - April 24 at 6:28 PM
Viatris Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support Access to Medicine and HealthcareViatris Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support Access to Medicine and Healthcare
finanznachrichten.de - April 19 at 12:50 PM
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
zacks.com - April 18 at 12:16 PM
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
finance.yahoo.com - April 16 at 5:25 PM
Viatris Inc.: Viatris Appoints Corinne Le Goff as Chief Commercial OfficerViatris Inc.: Viatris Appoints Corinne Le Goff as Chief Commercial Officer
finanznachrichten.de - April 15 at 4:22 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

FOX logo

FOX

NASDAQ:FOX
Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through Cable Network Programming; Television; and Other, Corporate and Eliminations segments. The Cable Network Programming segment produces and licenses news, business news, and sports content for distribution through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies, virtual multi-channel video programming distributors, and other digital platforms primarily in the U.S. Television segment produces, acquires, markets, and distributes programming through the FOX broadcast network, advertising supported video-on-demand service Tubi, and power broadcast television stations including duopolies and other digital platform; and engages in production of content for company and third parties. Other, Corporate and Eliminations segment comprises the FOX Studio Lot which provides television and film production services including office space, studio operation services, and facility operations; and Credible, a U.S. consumer finance marketplace. The company was incorporated in 2018 and is headquartered in New York, New York.
General Motors logo

General Motors

NYSE:GM
General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.
Harley-Davidson logo

Harley-Davidson

NYSE:HOG
Harley-Davidson, Inc. manufactures and sells motorcycles in the United States and internationally. The company operates in three segments: Harley-Davidson Motor Company, LiveWire, and Harley-Davidson Financial Services. The Harley-Davidson Motor Company segment designs, manufactures, and sells motorcycles, including cruiser, trike, touring, standard, sportbike, adventure, and dual sport, as well as motorcycle parts, accessories, and apparel, as well as licenses its trademarks and related services. This segment sells its products to retail customers through a network of independent dealers, as well as e-commerce channels. The LiveWire segment sells electric motorcycles, balance bikes for kids, parts and accessories, apparel, and related parts and services. The Harley-Davidson Financial Services segment provides wholesale financing services, such as floorplan and open account financing of motorcycles, and parts and accessories; and retail financing services, such as installment lending for the purchase of new and used Harley-Davidson motorcycles, as well as point-of-sale insurance and voluntary protection products. This segment also licenses third-party financial institutions that issue credit cards bearing the Harley-Davidson brand. Harley-Davidson, Inc. was founded in 1903 and is based in Milwaukee, Wisconsin.
Eli Lilly and Company logo

Eli Lilly and Company

NYSE:LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
TEGNA logo

TEGNA

NYSE:TGNA
TEGNA Inc., a media company, provides broadcast advertising and marketing products and services for businesses. The company operates 47 television stations in 39 markets of the United States that produce local programming, such as news, sports, and entertainment. It offers local and national non-political advertising; political advertising; production of programming from third parties; production of advertising materials; and digital marketing services, as well as advertising services on the stations' Websites, tablets, and mobile products. The company also sells commercial advertising spots of its television stations. In addition, it operates Premion, an over the top local advertising network; Hatch, a centralized 360-degree marketing services agency; and radio broadcast stations. The company was formerly known as Gannett Co., Inc. and changed its name to TEGNA Inc. in June 2015. TEGNA Inc. was founded in 1906 and is headquartered in McLean, Virginia.
THOR Industries logo

THOR Industries

NYSE:THO
THOR Industries, Inc. designs, manufactures, and sells recreational vehicles (RVs), and related parts and accessories in the United States, Canada, and Europe. The company offers travel trailers; gasoline and diesel Class A, Class B, and Class C motorhomes; conventional travel trailers and fifth wheels; luxury fifth wheels; and motorcaravans, caravans, campervans, and urban vehicles. It also provides aluminum extrusion and specialized component products to RV and other manufacturers. The company provides its products through independent and non-franchise dealers. THOR Industries, Inc. was incorporated in 1980 and is based in Elkhart, Indiana.
Viatris logo

Viatris

NASDAQ:VTRS
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.